Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Ownership - Who Owns Sarepta Therapeutics?

2,989 Followers

Sarepta Therapeutics (SRPT) Ownership Overview

449.42%2741.07%3049.80%1699.49%
449.42% Insiders
3049.80% Other Institutional Investors
― ETFs
1699.49% Public Companies and Individual Investors
The ownership structure of Sarepta Therapeutics (SRPT) stock is a mix of institutional, retail, and individual investors. , 449.42% is owned by Insiders, and 1699.49% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 03, 2024
xxxxxxxxxxxxx
$822100
Aug 20, 2024
xxxxxxxxxxxxx
$4955728
Mar 11, 2024
xxxxxxxxxxxxx
$93550
Mar 11, 2024
xxxxxxxxxxxxx
$1848795

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,383,869Institution8.79%1,044,043,207
7,815,886Institution8.20%973,312,284
6,184,249Institution6.48%770,124,528
3,181,688Insider3.34%396,215,607
3,015,791Institution3.16%375,556,453
2,637,960Institution2.77%328,505,159
2,295,000Institution2.41%285,796,350
1,815,117Institution1.90%226,036,520
1,676,461Institution1.76%208,769,688
1,540,079Institution1.61%191,786,038

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,815,886Institution8.20%973,312,284
2,637,960Institution2.77%328,505,159
1,815,117Institution1.90%226,036,520
1,676,461Institution1.76%208,769,688
1,540,079Institution1.61%191,786,038
1,264,046Institution1.33%157,411,648
949,449Institution1.00%118,234,884
943,691Institution0.99%117,517,840
894,400Institution0.94%111,379,632
884,799Institution0.93%110,184,019

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,852,183Institution2.99%387,269,408
2,985,345Institution3.13%371,765,013
2,271,557Institution2.38%308,432,009
1,589,517Institution1.67%198,435,302
1,444,868Institution1.52%196,184,177
1,256,483Institution1.32%170,605,262
763,401Institution0.80%95,066,327
658,965Institution0.69%82,060,911
495,292Institution0.52%61,678,713
482,515Institution0.51%60,087,593

FAQ

Who Owns Sarepta Therapeutics (SRPT)?
According to the latest TipRanks data, approximately 3049.80% of the company's stock is held by institutional investors, 449.42% is held by insiders, and 1699.49% is held by retail investors.
    What percentage of Sarepta Therapeutics (SRPT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3049.80% of Sarepta Therapeutics (SRPT) stock is held by institutional investors.
      What percentage of Sarepta Therapeutics (SRPT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 1699.49% of Sarepta Therapeutics (SRPT) stock is held by retail investors.
        Who owns the most shares of Sarepta Therapeutics (SRPT)?
        Vanguard owns the most shares of Sarepta Therapeutics (SRPT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis